Literature DB >> 17096066

Cholesterol-fed rabbit as a unique model of nonalcoholic, nonobese, non-insulin-resistant fatty liver disease with characteristic fibrosis.

Mosaburo Kainuma1, Makoto Fujimoto, Nobuyasu Sekiya, Koichi Tsuneyama, Chunmei Cheng, Yasuo Takano, Katsutoshi Terasawa, Yutaka Shimada.   

Abstract

BACKGROUND: The number of patients suffering from metabolic syndrome is increasing rapidly. Metabolic syndrome causes severe pathological changes in various organs, including the liver, and its main phenotype is nonalcoholic fatty liver disease (NAFLD). NAFLD has a broad spectrum ranging from simple fatty change to severe steatohepatitis with marked fibrosis. Recently, several experimental animal models for NAFLD have been proposed. However, most were established by rather artificial conditions such as genetic alteration. In the present study, we tried to establish a unique animal model mimicking some of the physiopathological features of NAFLD using high-cholesterol-fed rabbits.
METHODS: Male rabbits fed with standard rabbit food containing 1% cholesterol for 8 weeks and 12 weeks were compared to controls (six rabbits/group). The weight of food was strictly restricted to 100 g/rabbit per day.
RESULTS: Body weights and fasting plasma insulin levels showed no significant differences among the groups. In contrast, characteristic fine fibrosis was extended from perivenular to pericellular areas, and microvesicular fatty change with ballooning degeneration was observed in perivenular areas in livers of the cholesterol-fed rabbits. Increase of serum cholesterol level, activation of hepatic stellate cells, and exposure to oxidative stress were also recognized.
CONCLUSIONS: Cholesterol-fed rabbits share several physiopathological features of NAFLD. Because this model did not show insulin resistance or obesity, it may be useful for elucidating the mechanism of NAFLD related mainly to hyperlipidemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17096066     DOI: 10.1007/s00535-006-1883-1

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   6.772


  39 in total

Review 1.  Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance.

Authors:  O F James; C P Day
Journal:  J Hepatol       Date:  1998-09       Impact factor: 25.083

Review 2.  Metals, oxidative stress, and hepatic fibrogenesis.

Authors:  A Pietrangelo
Journal:  Semin Liver Dis       Date:  1996-02       Impact factor: 6.115

3.  Prevalence of and risk factors for hepatic steatosis in Northern Italy.

Authors:  S Bellentani; G Saccoccio; F Masutti; L S Crocè; G Brandi; F Sasso; G Cristanini; C Tiribelli
Journal:  Ann Intern Med       Date:  2000-01-18       Impact factor: 25.391

4.  Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association.

Authors:  Gianfranco Pagano; Giovanni Pacini; Giovanni Musso; Roberto Gambino; Fabio Mecca; Nadia Depetris; Maurizio Cassader; Ezio David; Paolo Cavallo-Perin; Mario Rizzetto
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

5.  NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome.

Authors:  Shivakumar Chitturi; Shehan Abeygunasekera; Geoffrey C Farrell; Jane Holmes-Walker; Jason M Hui; Caroline Fung; Rooshdiya Karim; Rita Lin; Dev Samarasinghe; Christopher Liddle; Martin Weltman; Jacob George
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

6.  Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

Authors:  C A Matteoni; Z M Younossi; T Gramlich; N Boparai; Y C Liu; A J McCullough
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

7.  The antioxidant (-)-epigallocatechin-3-gallate inhibits activated hepatic stellate cell growth and suppresses acetaldehyde-induced gene expression.

Authors:  Anping Chen; Li Zhang; Jianye Xu; Jun Tang
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

8.  Centrolobular liver fibrosis in the hypercholesterolemic rabbit.

Authors:  N Buyssens; M M Kockx; A G Herman; J M Lazou; K Van den Berg; E Wisse; A Geerts
Journal:  Hepatology       Date:  1996-10       Impact factor: 17.425

9.  Hepatic sinusoidal fibrosis induced by cholesterol and stilbestrol in the rabbit: 1. Morphology and inhibition of fibrogenesis by dipyridamole.

Authors:  I R Wanless; J Belgiorno; P M Huet
Journal:  Hepatology       Date:  1996-10       Impact factor: 17.425

10.  Nonalcoholic steatohepatitis: an expanded clinical entity.

Authors:  B R Bacon; M J Farahvash; C G Janney; B A Neuschwander-Tetri
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

View more
  26 in total

Review 1.  The effects of cholesterol on learning and memory.

Authors:  Bernard G Schreurs
Journal:  Neurosci Biobehav Rev       Date:  2010-05-12       Impact factor: 8.989

2.  NIM811 (N-methyl-4-isoleucine cyclosporine), a mitochondrial permeability transition inhibitor, attenuates cholestatic liver injury but not fibrosis in mice.

Authors:  Hasibur Rehman; Venkat K Ramshesh; Tom P Theruvath; Insil Kim; Robert T Currin; Shailendra Giri; John J Lemasters; Zhi Zhong
Journal:  J Pharmacol Exp Ther       Date:  2008-09-18       Impact factor: 4.030

Review 3.  Is the control of dietary cholesterol intake sufficiently effective to ameliorate nonalcoholic fatty liver disease?

Authors:  Munechika Enjoji; Makoto Nakamuta
Journal:  World J Gastroenterol       Date:  2010-02-21       Impact factor: 5.742

4.  Efficacy of garcinia cambogia on body weight, inflammation and glucose tolerance in high fat fed male wistar rats.

Authors:  Ramalingam Sripradha; Sridhar Gopalakrishna Magadi
Journal:  J Clin Diagn Res       Date:  2015-02-01

5.  Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH.

Authors:  Yuki Kimura; Hideyuki Hyogo; Sho-ichi Yamagishi; Masayoshi Takeuchi; Tomokazu Ishitobi; Yoshitaka Nabeshima; Koji Arihiro; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2010-01-30       Impact factor: 7.527

6.  Dietary cholesterol degrades rabbit long term memory for discrimination learning but facilitates acquisition of discrimination reversal.

Authors:  Bernard G Schreurs; Carrie A Smith-Bell; Desheng Wang; Lauren B Burhans
Journal:  Neurobiol Learn Mem       Date:  2013-09-25       Impact factor: 2.877

Review 7.  Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence.

Authors:  Shira Zelber-Sagi; Vlad Ratziu; Ran Oren
Journal:  World J Gastroenterol       Date:  2011-08-07       Impact factor: 5.742

Review 8.  Dietary habits and behaviors associated with nonalcoholic fatty liver disease.

Authors:  Kenichiro Yasutake; Motoyuki Kohjima; Kazuhiro Kotoh; Manabu Nakashima; Makoto Nakamuta; Munechika Enjoji
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

9.  Dietary cholesterol increases ventricular volume and narrows cerebrovascular diameter in a rabbit model of Alzheimer's disease.

Authors:  B G Schreurs; C A Smith-Bell; S K Lemieux
Journal:  Neuroscience       Date:  2013-09-14       Impact factor: 3.590

10.  Ex vivo study of quantitative ultrasound parameters in fatty rabbit livers.

Authors:  Goutam Ghoshal; Roberto J Lavarello; Jeremy P Kemmerer; Rita J Miller; Michael L Oelze
Journal:  Ultrasound Med Biol       Date:  2012-10-11       Impact factor: 2.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.